We are live on ! Find out more
VSTM icon

Verastem

61 hedge funds and large institutions have $120M invested in Verastem in 2023 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 18 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

196% more capital invested

Capital invested by funds: $40.5M → $120M (+$79.4M)

59.89% more ownership

Funds ownership: 4.06%63.94% (+60%)

28% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 18

4% less call options, than puts

Call options by funds: $451K | Put options by funds: $469K

24% less funds holding

Funds holding: 8061 (-19)

56% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 34

Holders
61
Holders Change
-19
Holders Change %
-23.75%
% of All Funds
0.96%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
23
Reduced
18
Closed
34
Calls
$451K
Puts
$469K
Net Calls
-$18K
Net Calls Change
-$33K

VSTM Hedge Fund Activity: Q2 2023 in Review

61 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Verastem (VSTM) for Q2 2023, worth a combined $120M — up 196% from $40.5M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of VSTM and 15 opened new positions — a net loss of 19 holders — while 18 trimmed existing stakes and 23 added.

The largest buyer was Deerfield Management, opening a new position worth an estimated $10.7M. The largest seller was Baker Bros. Advisors, cutting an estimated $5.48M.

  • 61 institutional investors held Verastem (VSTM) as of Q2 2023, down from 80 in Q1 2023.
  • Funds reported $120M of Verastem stock for Q2 2023, up 196% quarter-over-quarter.
  • 15 funds opened new Verastem positions in Q2 2023 and 34 closed out, a net change of -19 holders.
  • The largest Verastem buyer in Q2 2023 was Deerfield Management, an estimated $10.7M added.
  • The largest Verastem seller in Q2 2023 was Baker Bros. Advisors, an estimated $5.48M sold.

Based on aggregated 13F filings for Q2 2023.